Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - TOTAL RECEIVABLES
Total Receivables APLS - Apellis Pharmaceuticals, Inc.
206 M
LAST VALUE
352.04%
2 YEAR CAGR
0.00%
5 YEAR CAGR
123.22%
10 YEAR CAGR